Detailed information for compound 1905479

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 305.501 | Formula: C19H35N3
  • H donors: 0 H acceptors: 1 LogP: 5.85 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCCCCCCCN(c1ccccn1)CCN(C)C
  • InChi: 1S/C19H35N3/c1-4-5-6-7-8-9-10-13-16-22(18-17-21(2)3)19-14-11-12-15-20-19/h11-12,14-15H,4-10,13,16-18H2,1-3H3
  • InChiKey: BSTRXZLNRYXZOZ-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Integrin alpha pat-2 precursor 0.0118 0.0204 0.0204
Trichomonas vaginalis hypothetical protein 0.0097 0.013 1
Brugia malayi EGF-like domain containing protein 0.0097 0.013 0.013
Loa Loa (eye worm) hypothetical protein 0.0097 0.013 0.013
Schistosoma mansoni integrin alpha 0.0118 0.0204 0.0351
Trypanosoma brucei mitochondrial DNA polymerase beta 0.0331 0.093 1
Echinococcus multilocularis integrin alpha 3 0.0091 0.011 0.0015
Schistosoma mansoni alpha-galactosidase/alpha-n-acetylgalactosaminidase 0.0087 0.0099 0.0171
Onchocerca volvulus 0.0097 0.013 0.5
Echinococcus multilocularis integrin beta 2 0.222 0.7357 1
Brugia malayi Integrin alpha cytoplasmic region family protein 0.0089 0.0106 0.0106
Mycobacterium ulcerans hypothetical protein 0.0175 0.0396 0.5
Loa Loa (eye worm) hypothetical protein 0.0097 0.013 0.013
Brugia malayi hypothetical protein 0.026 0.0685 0.0685
Echinococcus granulosus Solute carrier family 22 5 0.0883 0.2807 0.3731
Loa Loa (eye worm) hypothetical protein 0.0065 0.0024 0.0024
Echinococcus multilocularis fibrillin 1 0.0097 0.013 0.0043
Schistosoma mansoni alpha-galactosidase/alpha-n-acetylgalactosaminidase 0.0087 0.0099 0.0171
Loa Loa (eye worm) integrin alpha pat-2 0.0182 0.0422 0.0422
Echinococcus multilocularis fibrillin 2 0.0097 0.013 0.0043
Echinococcus multilocularis Mitotic checkpoint protein PRCC, C terminal 0.0107 0.0167 0.0094
Schistosoma mansoni hypothetical protein 0.0107 0.0167 0.0288
Brugia malayi EGF-like domain containing protein 0.0097 0.013 0.013
Echinococcus multilocularis survival motor neuron protein 1 0.026 0.0685 0.0807
Brugia malayi Kelch motif family protein 0.0455 0.1351 0.1351
Giardia lamblia Tenascin-37 0.0097 0.013 0.5
Echinococcus granulosus fibrillin 2 0.0097 0.013 0.0043
Giardia lamblia High cysteine protein 0.0097 0.013 0.5
Brugia malayi EGF-like domain containing protein 0.0097 0.013 0.013
Trichomonas vaginalis teneurin and N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase, putative 0.0097 0.013 1
Leishmania major mitochondrial DNA polymerase beta 0.0331 0.093 1
Loa Loa (eye worm) hypothetical protein 0.0089 0.0106 0.0106
Schistosoma mansoni alpha-galactosidase/alpha-n-acetylgalactosaminidase 0.0087 0.0099 0.0171
Loa Loa (eye worm) hypothetical protein 0.0097 0.013 0.013
Echinococcus multilocularis thyroid hormone receptor alpha 0.0161 0.0351 0.0347
Loa Loa (eye worm) hypothetical protein 0.0455 0.1351 0.1351
Giardia lamblia Tenascin precursor 0.0097 0.013 0.5
Echinococcus granulosus tumor protein p63 0.0288 0.0783 0.0942
Giardia lamblia High cysteine protein 0.0097 0.013 0.5
Giardia lamblia Tenascin-like 0.0097 0.013 0.5
Loa Loa (eye worm) integrin beta-2 0.2997 1 1
Echinococcus granulosus fibrillin 1 0.0097 0.013 0.0043
Echinococcus multilocularis adam 0.0097 0.013 0.0043
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.0331 0.093 1
Giardia lamblia hypothetical protein 0.0097 0.013 0.5
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.0331 0.093 1
Loa Loa (eye worm) kelch domain-containing protein family protein 0.0455 0.1351 0.1351
Echinococcus granulosus integrin beta 2 0.222 0.7357 1
Schistosoma mansoni thyroid hormone receptor 0.0161 0.0351 0.0604
Toxoplasma gondii hypothetical protein 0.0097 0.013 1
Echinococcus granulosus adam 0.0097 0.013 0.0043
Loa Loa (eye worm) hypothetical protein 0.0097 0.013 0.013
Schistosoma mansoni integrin beta subunit 0.1765 0.5807 1
Giardia lamblia Tenascin-X 0.0097 0.013 0.5
Brugia malayi hypothetical protein 0.0455 0.1351 0.1351
Echinococcus granulosus Mitotic checkpoint protein PRCC C terminal 0.0107 0.0167 0.0094
Echinococcus multilocularis protein jagged 2 0.0097 0.013 0.0043
Echinococcus granulosus integrin alpha 3 0.0091 0.011 0.0015
Loa Loa (eye worm) hypothetical protein 0.0093 0.0118 0.0118
Giardia lamblia Neurogenic locus Notch protein precursor 0.0097 0.013 0.5
Giardia lamblia Neurogenic locus notch-like protein 0.0097 0.013 0.5
Loa Loa (eye worm) hypothetical protein 0.026 0.0685 0.0685
Echinococcus granulosus survival motor neuron protein 1 0.026 0.0685 0.0807
Mycobacterium tuberculosis Conserved hypothetical protein 0.0175 0.0396 0.5
Brugia malayi EGF-like domain containing protein 0.0097 0.013 0.013
Schistosoma mansoni alpha-galactosidase/alpha-n-acetylgalactosaminidase 0.0087 0.0099 0.0171
Schistosoma mansoni thyroid hormone receptor 0.0161 0.0351 0.0604
Echinococcus multilocularis tumor protein p63 0.0288 0.0783 0.0942

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.